Navigation Links
Upsher-Smith Introduces Nexa™ Select With More Plant-Based DHA Than Any Other Once-Daily Single Gel Capsule Rx Prenatal Vitamin
Date:2/7/2011

MAPLE GROVE, Minn., Feb. 7, 2011 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. announces the launch of Nexa™ Select Rx prenatal vitamin, the newest addition to the Nexa™ Prenatal Vitamin Family.  Nexa™ Select contains plant-based DHA (325 mg) and Vitamin D3 (800 IU). Its advanced formulation offers more plant-based DHA than any other single gel capsule Rx prenatal vitamin taken once a day.  Many experts recommend a DHA intake of at least 200 to 300 mg per day for women during pregnancy and lactation.

Women who are pregnant, breastfeeding or trying to become pregnant can feel confident that while taking a prenatal vitamin with plant-based DHA, they are avoiding the potential worry of exposure to oceanborne toxins, such as mercury or polychlorinated biphenyl (PCB) compounds, and the fishy aftertaste or burp that may be associated with fish-based DHA.

"There is no more important time to eat a nutritious diet than during pregnancy.  Even the most conscientious mothers-to-be can benefit from the added nutritional support that prenatal vitamins provide," said Wesley Mark Todd, MD, Senior Director Medical Affairs, Upsher-Smith Laboratories, Inc. "While Nexa™ Select includes numerous vitamins and minerals to support a healthy pregnancy, the folic acid and plant-based DHA in a single capsule are especially appealing to many moms-to-be."

Nexa™ Select also provides 800 IU of vitamin D3 an essential vitamin to support mom and baby's skeletal health, 1.25 mg of folic acid and 29 mg of iron. It also contains other essential vitamins and minerals that are important for the overall health and well-being of mother and baby, including calcium and vitamins B6 and C -- as well as the gentle stool softener, docusate sodium, for added comfort.  

About DHADHA, or docosahexaenoic acid, is a key omega-3 fatty acid that is associated with a host of health benefits for mothers and babies. It helps with the development of baby's prenatal and postnatal brain and visual development. Some studies suggest that omega-3 fatty acids may promote a healthy duration of gestation and birth weight. Nexa™ Select contains plant-based life'sDHA™ which has been granted GRAS (Generally Recognized As Safe) status by the FDA for use in infant formula.  

Product InformationThe NDC number for Nexa™ Select is 0245-0244-30.  Key product features include: 30 gel capsules per bottle, a vanilla-scent, and a regimen of one capsule once daily.  

Important Safety InformationWARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six.  KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.  In case of accidental overdose, call a doctor or poison control center immediately.

Please see full Prescribing Information for a complete list of warnings and precautions. http://www.nexaprenatal.com/full-prescribing-information/

For additional information about Nexa™ Select, visit www.nexaprenatal.com.

About Upsher-SmithUpsher-Smith Laboratories, Inc. is a rapidly growing pharmaceutical company that manufactures and markets both prescription and consumer products.  Privately held since 1919, the company strives to recognize the unmet healthcare needs of its customers.  Upsher-Smith prides itself on providing safe, effective, and economical therapies to the ever-challenged healthcare environment.  To learn more about Upsher-Smith, visit www.upsher-smith.com.SourcesNexa Select [package insert]. Minneapolis, MN: Upsher-Smith Laboratories, Inc; 2011. PreNexa  [package insert]. Minneapolis, MN: Upsher-Smith Laboratories, Inc; 2010. CitraNatal Harmony [package insert]. San Antonio, TX: Mission Pharmacal Company; 2010. Concept DHA [package insert]. Decatur, GA: US Pharmaceutical Corp; 2009. Natelle One [package insert]. Philadelphia, PA: Azur Pharma, Inc; 2009. Neevo DHA [package insert]. Covington, LA: PamLab, LLC; 2009. OB Complete [package insert]. Sayreville, NJ: Vertical Pharmaceuticals, Inc; 2010. Prefera OB ONE [package insert]. Marietta, GA: Alaven Pharmaceutical LLC; 2010. Prenate Essential [package insert]. Atlanta, GA: Shionogi Pharma Inc; 2010.Koletzko B, et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy. J Perinat Med. 2008;36:5-14. Simonopoulos AP, Leaf A,  Salem N Jr. Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty  acids. J Am Coll Nutr. 1999;18:487-489.Martek Biosciences Corporation. Annual Report 2009. Columbia, MD. Some "healthy" fish oil supplements come with serious chemical contamination; lawsuit to force warnings. Fish oil safety Website.http://org2.democracyinaction.org/o/6491/p/salsa/web/press_release/public/?press_release_KEY=36. Accessed October 4, 2010.Environmental Defense Fund. Fish oil supplements. http://www.edf.org/page.cfm?tagID=16536.  Accessed October 4, 2010.Mulligan ML, Felton SK, Riek AE, et al.  Implications of vitamin D deficiency in pregnancy and lactation. Am J Obstet Gynecol 2009;201.Medline Plus. http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-fishoil.html.  Accessed November 1, 2010. Koletzko B, Larque E, Demmelmair H. Placental transfer of long-chain polyunsaturated fatty acids (LC-PUFA). J Perinat Med. 2007;35 (suppl 1):S5-S11.  Smuts C, et al. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. 2003;101:469.US Food and Drug Administration. Agency Response Letter GRAS No. GRN000041 [May 17, 2001].http://www.fda.gov/Food/FoodIngredientsPackaging/GenerallyRecognizedasSafeGRAS/GRASListings/ucm154126.htm. Accessed October 4, 2010.Harris WS. Fish oil supplementation: evidence for health benefits. Cleve Clin J Med. 2004;71(3):208-221.life'sDHA is a trademark of Martek Biosciences Corporation.
'/>"/>

SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Upsher-Smith Announces New Formulation of PreNexa(R) Prenatal Vitamins
2. New Data: Cholesterol Management Analysis of Upsher-Smiths Slo-Niacin(R) Tablets in Combination with Lipitor(R)
3. Upsher-Smith Announces Milestone in Development of CNS Strategy
4. Upsher-Smith Introduces New Formulation of PreNexa® Prenatal Vitamins
5. Upsher-Smith Laboratories Announces Initiation of Phase III Clinical Trial of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
6. Upsher-Smith Laboratories Adds ITI-111 (Nasal Midazolam) to CNS Development Pipeline
7. Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem® 10 mcg
8. Upsher-Smith Laboratories Announces Initiation of Open-Label Extension Study of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
9. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
10. Dr. Dello Russo Introduces the New EYE-Q Lasik
11. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
Breaking Medicine Technology:
(Date:4/28/2017)... New York, NY (PRWEB) , ... April 28, ... ... Shiel Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast ... indicates recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back Surgery and ... revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified Anesthesiologist, with ... revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike traditional back ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The Texas ... in recently to the labor and delivery team at Women’s Hospital at Renaissance in ... who give birth at the hospital and decide to donate. , “Women’s Hospital ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... hERG liability could substantially improve drug safety and minimize the cost of development. ... validating ion channel inhibition using cell lines and for cardiac toxicity using induced ...
Breaking Medicine News(10 mins):